VANCOUVER, BRITISH COLUMBIA, March 16, 2022- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB-FF). Pascal has signed a term sheet dated March 16, 2022 with Shape Capital Pty Ltd. of Melbourne, Victoria (“Shape”), an investment and advisory…

VANCOUVER, BRITISH COLUMBIA, March 14, 2022- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB-FF). Pascal has arranged for the settlement of up to $474,812 in payables with the issuance of up to 5,935,151 common shares of the…

VANCOUVER, BRITISH COLUMBIA, March 1, 2022- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB-FF), is pleased to announce today the appointment of Dr. Brian Bapty as Chief Executive Officer and President, for a five year term which…